HQ
Columbus, OH
Founders and CEO
Timothy Tracy, CEO
Sector
Life Sciences

Company Profile

Breast Cancer is the second most common cancer malignancy in women and discourages survival rates at the metastatic stage. Koru Biopharma’s lead compound, an antibody fragment, targets various cancer cells, including breast cancer, and prevents abnormal cell division.